T. Rowe Price Associates’s Treace Medical Concepts TMCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $131K | Buy |
22,117
+1,118
| +5% | +$6.62K | ﹤0.01% | 2837 |
|
|
2025
Q1 | $177K | Buy |
20,999
+1,943
| +10% | +$16.4K | ﹤0.01% | 2689 |
|
|
2024
Q4 | $142K | Buy |
19,056
+3,452
| +22% | +$25.7K | ﹤0.01% | 2770 |
|
|
2024
Q3 | $91K | Hold |
15,604
| – | – | ﹤0.01% | 2837 |
|
|
2024
Q2 | $104K | Buy |
15,604
+2,632
| +20% | +$17.5K | ﹤0.01% | 2755 |
|
|
2024
Q1 | $170K | Buy |
12,972
+1,385
| +12% | +$18.2K | ﹤0.01% | 2666 |
|
|
2023
Q4 | $148K | Buy |
11,587
+1,107
| +11% | +$14.1K | ﹤0.01% | 2632 |
|
|
2023
Q3 | $138K | Buy |
10,480
+1,323
| +14% | +$17.4K | ﹤0.01% | 2591 |
|
|
2023
Q2 | $235K | Buy |
+9,157
| New | +$235K | ﹤0.01% | 2465 |
|